§ Federal grant opportunity · HT942526AZRPTRDA
DoW Alzheimer’s Transforming Diagnosis Award
Defense Health Agency Contracting Activity - DHACA is accepting applications for DoW Alzheimer’s Transforming Diagnosis Award. The deadline is September 24, 2026 and the published award range is Award amount not published.
Key facts
- Funder
- Defense Health Agency Contracting Activity - DHACA
- Application deadline
- September 24, 2026
- Award range
- Award amount not published
- Eligibility
- Eligibility criteria are published in the funding opportunity announcement.
- Geography
- United States
- Focus areas
- Research
- Opportunity number
- HT942526AZRPTRDA
Program overview
Summary: The fiscal year 2026 (FY26) Alzheimer’s Research Program (AZRP) Transforming Diagnosis Award (TrDA) supports non-incremental, solutions-oriented research that reduces or overcomes important barriers to obtaining a diagnosis, meaningful disease monitoring and accurate prognosis. Distinctive Features: Clinical research is allowed, however clinical trials and animal research are prohibited. Preliminary data are required. Community collaboration is required for studies prospectively enrolling human subjects. Study Population: The AZRP encourages studies to leverage existing cohorts/datasets. Cohorts consisting of individuals 65 years or younger are also encouraged. Career Initiation or Transition (CIT) Partnership Option: The TrDA includes an option for more than one PI and supports both new and existing collaborative partnerships. If recommended for funding, each PI will be named on separate awards to the recipient organization(s). If utilizing this option, at least one independent investigator must meet the CIT Partnership Option eligibility requirements at the time of application submission.
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from Defense Health Agency Contracting Activity - DHACA.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before September 24, 2026, allowing time for registration and validation.
Related grant opportunities
- Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional)
- BJA FY 2026 Comprehensive Opioid, Stimulant, and Substance Use Site-Based Program
- BJA FY 2026 Local Law Enforcement Crime Gun Intelligence Center Integration Initiative
- BJA FY 2026 Second Chance Act Family-Based Substance Use Disorder Treatment Program
- BJA FY 2026 Second Chance Act Improving Reentry Education and Employment Outcomes
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.